Tag Archive | "GSK"

GSK and J&J are pharma partnering for Ebola vaccine

Tags: , ,

GlaxoSmithKline and Johnson & Johnson will become pharma partnering for increasing production of an Ebola vaccine, with an aim to produce at least 1 million doses next year. Read the full story

GSK and Anderson Cancer Center form a pharma alliance

Tags: , , ,

The University of Texas MD Anderson Cancer Center announced it formed a research alliance with GlaxoSmithKline to strengthen its efforts in advancing therapies that train the body's immune system to combat cancer. Read the full story

GSK acquires 25% stake in Aspen Pharmacare

Tags: , , , ,

GlaxoSmithKline will acquire a stake in the Japanese subsidiary of Aspen Pharmacare Holdings as part of an alliance to boost commercial operations in the Asian country. Read the full story

Morphosys: Clear leaders in antibody generation

Tags: , , ,

Morphosys is a leading biotechnology developing therapeutic antibodies for a range of different indications. Read the full story

Mylan bids on old drugs of GSK

Tags: , , , , ,

Several companies, including Mylan , have submitted a second round of bidding for a portfolio of older GlaxoSmithKline drugs.   Read the full story

Novartis signs multi-billion dollar pharma deal with GSK and Eli Lilly

Tags: , , , , , ,

Novartis signs pharma deal with GlaxoSmithKline and Eli Lilly for exchange of oncology, vaccine and animal health business units.  Read the full story

Merck and GSK enter into a pharma licensing deal

Tags: , , , ,

Merck enters into a pharma licensing deal with GSK for evaluating combination therapy for renal cell carcinoma. Read the full story

Dealtalk: Blackstone and Lion Capital to bid for Lucozade and Ribena from GSK

Tags: , , ,

In dealtalk, Blackstone and Lion Capital are to make a joint bid for Lucozade and Ribena from big pharma Roche. Read the full story

GSK inks pharma licensing deals with Renaissance Acquisition Holdings

Tags: , , ,

Renaissance Acquisition Holdings and GlaxoSmithKline, a big pharma company  have entered into pharma licensing deals agreement giving Renaissance the rights in the USA to manufacture, market and sell six dermatology and three anti-viral products from GSK Read the full story

GSK seals global pharma licensing development agreement with MorphoSys

Tags: , , , ,

MorphoSys have entered into a global pharma licensing agreement with GlaxoSmithKline to develop and commercialize MOR103 Read the full story